Clene Inc.
NASDAQ:CLNNBiotechnology
+$0.08 today
- Market cap
- $50.40M
- Beta
- 0.92
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$2.88
Volume 0.12M
Average 0.50M
Returns on capital
Clene Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
148.8%
avg -751.9%
ROIC
-188.6%
avg -94.7%
ROA
-144.4%
avg -67.0%
Analysis
ROE is currently the strongest return metric at 148.8% versus its period average of -751.9%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Robert Etherington | Chief Executive Officer, President & Director | USD 547.24K | 59 | — | — |
Mark G. Mortenson | Chief Science Officer | USD 441.07K | 68 | — | — |
Morgan R. Brown | Chief Financial Officer | USD 324.16K | 58 | 20.00K | 0.19% |
Mary Anne Mcneil | Head of Human Resources | — | — | — | — |
Jerry Miraglia | General Counsel & Corporate Secretary | — | — | — | — |
Benjamin Greenberg | Head of Medical | — | — | — | — |
Michael T. Hotchkin | Chief Development Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 20, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$216,664.50
Sells
62
$5.78M
Net Transaction Value
−$5.56M
Net selling
Most Active
Ugwumba Chidozie
62 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| May 12, 26May 12, 2026 | Ugwumba Chidozie Indirect | Sell | $454.4K$454,435.20 |
| May 11, 26May 11, 2026 | Ugwumba Chidozie Indirect | Sell | $149.7K$149,694.75 |
| May 4, 26May 4, 2026 | Ugwumba Chidozie Indirect | Sell | $495.6K$495,611.20 |
| May 1, 26May 1, 2026 | Ugwumba Chidozie Indirect | Sell | $34.8K$34,827.95 |
| Apr 30, 26Apr 30, 2026 | Ugwumba Chidozie Indirect | Sell | $34.9K$34,874.88 |
| Apr 29, 26Apr 29, 2026 | Ugwumba Chidozie Indirect | Sell | $68.5K$68,517.10 |
| Apr 28, 26Apr 28, 2026 | Ugwumba Chidozie Indirect | Sell | $9.4K$9,386.90 |
| Apr 21, 26Apr 21, 2026 | Ugwumba Chidozie Indirect | Sell | $376.7K$376,658.30 |
| Apr 20, 26Apr 20, 2026 | Ugwumba Chidozie Indirect | Sell | $26.4K$26,426.16 |
| Apr 17, 26Apr 17, 2026 | Ugwumba Chidozie Indirect | Sell | $161K$161,007.20 |
1–10 of 63
Summary
Insiders reported 1 buys worth $216,664.50 and 62 sells worth $5.78M over the last 12 months. That adds up to net selling of $5.56M. Ugwumba Chidozie was the most active insider with 62 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -24.9% | +392.8% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at -24.9% over three years. Forward estimates point to Revenue at +392.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Clene Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CLNN's management, answered from reported figures.
Who manages CLNN?
Clene Inc. (CLNN) lists 7 active executives. The top listed executive is Mark G. Mortenson, Chief Science Officer.
Are CLNN insiders buying or selling?
Recent insider activity shows net selling of $7.83M.
Continue the stock analysis
Jump to another research area for this company.